Back to top
more

Quest Diagnostics (DGX)

(Real Time Quote from BATS)

$146.17 USD

146.17
143,720

+0.16 (0.11%)

Updated Jul 22, 2024 10:36 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Quest Diagnostics (DGX) Tops Q3 Earnings, Revenues In Line

Considering hurricanes related financial impact and recently-closed acquisitions, Quest Diagnostics' (DGX) management has revised its guidance for full year 2017.

    Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?

    The overall soft industry trends leading to low volume environment may continue to put a dampener on Quest Diagnostics (DGX) in Q3. The reimbursement scenario also remains a major cause for concern.

      Is Quest Diagnostics (DGX) a Great Stock for Value Investors?

      Let's see if Quest Diagnostics (DGX) stock is a good choice for value-oriented investors right now from multiple angles.

        Why Is Quest Diagnostics (DGX) Down 3.9% Since the Last Earnings Report?

        Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

          Amedisys (AMED) Earnings & Revenues Miss Estimates in Q2

          Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business in Q2.

            Edwards Lifesciences (EW) Tops Q2 Earnings & Sales, View Up

            Edwards Lifesciences (EW) rides high on continued growth in its highly advanced Transcatheter Heart Valve space in Q2.

              Thermo Fisher (TMO) Tops Q2 Earnings & Revenues, View Up

              Thermo Fisher Scientific (TMO) continues to gain considerable synergies from FEI Company acquisition. A raised guidance buoys optimism.

                Quest Diagnostics (DGX) Tops Q2 Earnings, Raises '17 View

                Quest Diagnostics (DGX) continues to ride high on its advanced diagnostic offerings. Also, a raised view buoys optimism.

                  Quest Diagnostics (DGX) Tops Q2 Earnings, Misses on Sales

                  Quest Diagnostics (DGX) gains in Q2 banking on the acquisition of Med Fusion and ClearPoint.

                    Healthcare Q2 Earnings Slated on Jul 25: HCA, UHS & More

                    The healthcare sector continues to benefit from higher enrollments, mergers and acquisitions, partly offset by high expense on account of acquisition integration and investments in technology.

                      Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas

                      Quest Diagnostics (DGX) acquires Med Fusion and Clear Point lab businesses to grow in oncology space.

                        Can Quest Diagnostics (DGX) Pull a Surprise in Q2 Earnings?

                        Weak revenue per requisition performance and reimbursement pressure might dampen Quest Diagnostics' (DGX) benefits from esoteric testing business, infectious disease testing and prescription drug monitoring business growth.

                          3 Excellent Value Picks Amid Political Grind in MedTech

                          While the revised American Health Care Act now only needs the Senate's nod, the scenario is getting increasingly challenging for the Medical Device Space.

                            Here's Why You Can Buy Quest Diagnostics Stock Right Now

                            Quest Diagnostics Incorporated (DGX) is on a healthy growth trajectory of late.

                              Quest Diagnostics to Buy Outreach Lab Service in Cape Cod

                              Quest Diagnostics Inc. (DGX) recently teamed up with Cape Cod Healthcare (CCHC) to obtain its outreach laboratory service business.

                                Quest Diagnostics Enhances Blueprint for Athletes Service

                                Quest Diagnostics Inc. (DGX), a global provider of clinical lab services, recently expanded its biomarker testing service known as Blueprint for Athletes.

                                  Why Quest Diagnostics (DGX) is a Suitable Pick for Investors

                                  Madison, NJ-based Quest Diagnostics, Inc. (DGX), a provider of commercial laboratory services, has been on a growth trajectory of late.

                                    Why You Should Avoid Envision Healthcare (EVHC) Stock Now

                                    Investors' pessimism about Envision Healthcare (EVHC) has stemmed from the decline in 2017 earnings guidance, following first-quarter results.

                                      Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space

                                      Quest Diagnostics (DGX) recently announced agreements to acquire two laboratory businesses in Lewisville, Texas, namely Med Fusion and Clear Point.

                                        Quest Diagnostics (DGX) Up 1.8% Since Earnings Report: Can It Continue?

                                        Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                          Quest Diagnostics Poised on Solid Q1 Results Despite Woes

                                          On May 22, we issued an updated research report on Quest Diagnostics, Inc. (DGX), a major commercial laboratory services provider.

                                            Top Ranked Momentum Stocks to Buy for April 24th

                                            Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 24th:

                                              Quest Diagnostics (DGX) Looks Good: Stock Moves 6% Higher

                                              Quest Diagnostics Incorporated (DGX) shares rose to 6% in the last trading session.

                                                Quest Diagnostics (DGX) Tops Q1 Earnings & Sales Estimates

                                                Currently, Quest Diagnostics has a Zacks Rank #2 (Buy) but that could change following its strong first quarter 2017 earnings report which has just released.

                                                  Should You Sell Quest Diagnostics (DGX) Before Earnings?

                                                  Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.